Aurrigo looks to new international hub to generate royalty streams
8th Dec 2025 13:50
(Alliance News) - Aurrigo International PLC on Monday announced the launch of a new licensing and hub programme and the appointment of a joint broker. Read More
(Alliance News) - Aurrigo International PLC on Monday announced the launch of a new licensing and hub programme and the appointment of a joint broker. Read More
(Alliance News) - The Financial Conduct Authority on Monday set out new measures to build a "stronger investment culture" in the UK, "supporting firms to innovate and make investing more engaging for consumers." Read More
(Alliance News) - Frontier IP Group PLC on Monday said performance in financial 2025 was "solid" but was "hampered by difficult public and private market conditions." Read More
(Alliance News) - PureTech Health PLC on Monday said its idiopathic pulmonary fibrosis drug candidate deupirfenidone has cleared a key regulatory milestone, with the US Food & Drug Administration backing progression into a pivotal phase 3 trial planned for the first half of 2026. Read More
(Alliance News) - Big Technologies PLC on Monday said it is on track to meet full-year market consensus for earnings as it reported "rapid progress" in the second half in a trading update. Read More
(Alliance News) - A High Court challenge against the government's approval of plans to expand Luton Airport has been dismissed by a judge. Read More
(Alliance News) - CRH PLC is to join the S&P 500 later this month, according to an index rebalancing announced on Friday. Read More
(Alliance News) - Stock prices in London were mostly lower at midday on Monday, ahead of US consumer inflation expectations and comments from the Bank of England's deputy governor. Read More
(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Friday and Monday and not separately reported by Alliance News: Read More
(Alliance News) - Greengage & Co Group PLC on Monday said it intends to float on the Access segment of the Aquis Stock Exchange, alongside an accompanying fundraise. Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More
Avacta Group PLC - Wetherby, West Yorkshire-based life sciences company - Expects to announce initial faridoxorubicin phase 1b data in the salivary gland cancer indication next week Wednesday. Back in October, Avacta had said faridoxorubicin showed positive tolerability and safety in patents across both the every three weeks and every two weeks dosing regiments. Faridoxorubicin is a form of doxorubicin designed to reduce the systemic side effects of conventional chemotherapy and concentrate the active payload in the tumour microenvironment. Doxorubicin is a chemotherapy drug used to treat cancer. Read More
(Alliance News) - The following is a round-up of London-listed company director and manager changes announced on Friday and Monday and not separately reported by Alliance News: Read More
(Alliance News) - Hutchmed China Ltd on Monday said several of its oncology medicines will continue to be reimbursed under China's national insurance scheme next year, while one of its newer cancer drugs has secured a place on the country's first-ever commercial insurance drug list. Read More
(Alliance News) - Fermi Inc on Monday reported a definitive deal for Xcel Energy Inc to supply electric services to its Matador energy grid project. Read More